Trial Profile
Methyl aminolevulinate (MAL) and hexaminolevulinate (HAL) [hexyl aminolevulinate] photodynamic therapy (PDT) [photochemotherapy] of cervical intraepithelial lesions (SIL) - a double-blind dose-finding study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Hexyl aminolevulinate (Primary) ; Methyl aminolevulinate (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- Sponsors PhotoCure
- 29 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Oct 2006 New trial record.